title: Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer.
authors.affiliation: Translational Research, OSI Pharmaceuticals, Inc., Farmingdale, New York 11735, USA. ebuck@osip.com
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Buck
authors.forename: Prafulla C
authors.initials: PC
authors.lastname: Gokhale
authors.forename: Susan
authors.initials: S
authors.lastname: Koujak
authors.forename: Eric
authors.initials: E
authors.lastname: Brown
authors.forename: Alexandra
authors.initials: A
authors.lastname: Eyzaguirre
authors.forename: Nianjun
authors.initials: N
authors.lastname: Tao
authors.forename: Maryland
authors.initials: M
authors.lastname: Rosenfeld-Franklin
authors.forename: Lorena
authors.initials: L
authors.lastname: Lerner
authors.forename: M Isabel
authors.initials: MI
authors.lastname: Chiu
authors.forename: Robert
authors.initials: R
authors.lastname: Wild
authors.forename: David
authors.initials: D
authors.lastname: Epstein
authors.forename: Jonathan A
authors.initials: JA
authors.lastname: Pachter
authors.forename: Mark R
authors.initials: MR
authors.lastname: Miglarese